Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218744 · ClinicalTrials.gov registry record · Phase 1
Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants
A Phase 1 study of Healthy Participants, sponsored by Incyte Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT07218744: Completed Phase 1 study of Healthy Participants, sponsored by Incyte Corporation.
NCT07218744 is a Phase 1 study of Healthy Participants that has completed, run by Incyte Corporation. The registered enrollment target is 9 participants, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218744, a Phase 1 study of Healthy Participants, has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of \[14C\] INCB123667 in healthy male participants.
Primary Outcome
Radioactivity in urine and feces was reported as the percentage of the administered radioactivity excreted.
Conditions Studied
Interventions
- DRUG INCB123667
Study Locations (1)
Wisconsin
- Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2025-11-13 |
| Est. Completion | 2025-12-10 |
| Phase | Phase 1 |
What the finished NCT07218744 record still lists
NCT07218744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which INCB123667 is the first listed.
NCT07218744 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07218744 about?
NCT07218744 is a clinical study titled "Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants". This study will assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of \[14C\] INCB123667 in healthy male participants.
What is the current status of trial NCT07218744?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2025-11-13. Estimated completion is 2025-12-10.
What conditions does trial NCT07218744 study?
This clinical trial studies the following conditions: Healthy Participants.
What interventions are being tested in trial NCT07218744?
The interventions under investigation include: INCB123667 (DRUG).
Who is sponsoring clinical trial NCT07218744?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218744 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07218744's enrollment target sits among peer trials
9 117th of 119 higher than 3 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
RECRUITING · Phase 1
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
RECRUITING · Phase 1
-
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
RECRUITING · Phase 1
-
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
RECRUITING · Phase 1
-
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI